flufenamic acid has been researched along with luteolin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cahlikova, L; Chlebek, J; Havrankova, J; Hofman, J; Hostalkova, A; Lundova, T; Musilek, K; Novotna, E; Wsol, V; Zemanova, L | 1 |
| Arsequell, G; Blasi, D; Busquets, MA; Cardoso, I; Cotrina, EY; Gales, L; Gimeno, A; Jiménez-Barbero, J; Leite, JP; Liz, MA; Llop, J; Planas, A; Prohens, R; Quintana, J; Rivas, J; Santos, LM | 1 |
2 other study(ies) available for flufenamic acid and luteolin
| Article | Year |
|---|---|
Flavones Inhibit the Activity of AKR1B10, a Promising Therapeutic Target for Cancer Treatment.
Topics: Aldehyde Reductase; Aldo-Keto Reductases; Apigenin; Daunorubicin; Enzyme Inhibitors; Flavones; Flavonoids; HCT116 Cells; Humans; Luteolin; Molecular Conformation; Molecular Structure; Neoplasms | 2015 |
Targeting transthyretin in Alzheimer's disease: Drug discovery of small-molecule chaperones as disease-modifying drug candidates for Alzheimer's disease.
Topics: Alzheimer Disease; Calorimetry; Dose-Response Relationship, Drug; Drug Discovery; Humans; Models, Molecular; Molecular Chaperones; Molecular Structure; Prealbumin; Small Molecule Libraries; Software; Structure-Activity Relationship | 2021 |